Clinical Trial Update: TMC278-TiDP38-C145: A Bioavailability Study in Healthy Adult Volunteers to Evaluate 3 Pediatric Formulations of TMC278 (a Solution, a Suspension, and Granules) Compared to an Adult Tablet Formulation [Phase 1]

View source ↗

Summary

Phase 1 bioavailability study in healthy adult volunteers evaluating three pediatric formulations of TMC278 (rilpivirine) against the adult tablet formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TMC278 (rilpivirine) (rilpivirine)

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: Pharmacokinetics, Bioavailability | Phase 1 | Status: COMPLETED